Sargent Bickham Lagudis’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $87.7K | Buy |
215
+49
| +30% | +$20K | 0.01% | 357 |
|
|
2022
Q3 | $54K | Hold |
166
| – | – | ﹤0.01% | 398 |
|
|
2022
Q2 | $59K | Sell |
166
-100
| -38% | -$35.5K | 0.01% | 388 |
|
|
2022
Q1 | $146K | Sell |
266
-118
| -31% | -$64.8K | 0.01% | 287 |
|
|
2021
Q4 | $253K | Hold |
384
| – | – | 0.02% | 223 |
|
|
2021
Q3 | $239K | Sell |
384
-59
| -13% | -$36.7K | 0.02% | 229 |
|
|
2021
Q2 | $280K | Sell |
443
-40
| -8% | -$25.3K | 0.02% | 221 |
|
|
2021
Q1 | $236K | Sell |
483
-221
| -31% | -$108K | 0.02% | 219 |
|
|
2020
Q4 | $352K | Sell |
704
-105
| -13% | -$52.5K | 0.03% | 182 |
|
|
2020
Q3 | $318K | Buy |
809
+772
| +2,086% | +$303K | 0.03% | 175 |
|
|
2020
Q2 | $12K | Hold |
37
| – | – | ﹤0.01% | 552 |
|
|
2020
Q1 | $9K | Buy |
+37
| New | +$9K | ﹤0.01% | 567 |
|
|
2017
Q2 | – | Sell |
-6
| Closed | -$1K | – | 783 |
|
|
2017
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 723 |
|